“You may choose to look the other way, but you can never say again that you did not know.”
— William Wilberforce
Two years into the global pandemic of the novel coronavirus SARS-CoV-2, there is scant guidance from government agencies, universities, or professional medical organizations to help individuals recover from the SARS-CoV-2 infection that causes COVID-19 without the need for hospitalization. The U.S. Centers for Disease Control and Prevention (CDC), which recommends monoclonal antibodies for high-risk individuals […]
On Oct. 29, 2021 the U.S Food and Drug Administration (FDA) approved the use of Pfizer/BioNTech COVID-19 vaccine by five- to 11-year-old children under federal Emergency Use Authorization (EUA) guidelines. As California became the first state to announce that COVID vaccine will be required for children to attend school, districts in several other states plan […]
Merck and Pfizer have submitted Emergency Use Authorization (EUA) applications to the U.S. Food and Drug Administration (FDA) to authorize distribution of what would be the first antiviral drug specifically designed to treat COVID-19 disease.1 Merck/Ridgeback Biotherapeutics are seeking EUA approval for Molnupiravir (MK-4482/EIDD-2801), an investigational oral antiviral drug originally developed to treat influenza.2 Pfizer […]
One Oct 29, 2021, the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for the experimental messenger RNA (mRNA) Pfizer/BioNTech COVID-19 biologic BNT162b2 for children five to 11 years old. The FDA’s decision, which is based on a clinical trial earlier this year involving 2,268 kindergartners and elementary school-aged kids and an […]
On Oct. 20, 2021, the Biden administration outlined plans to begin giving COVID-19 vaccinations to children between five and 11 years old. Pending the results of reviews of the plan by the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) over the […]
As vaccines and mandates continue to be the primary means of combating COVID-19, findings from a recently published article demonstrate that COVID-19 cases across 68 countries and nearly 3,000 counties in the United States were unrelated to vaccination rates, indicating “a lack of meaningful association.”1 The international data, published in the European Journal of Epidemiology, […]
A 37-year-old woman in King County, Washington died unexpectedly on Sept. 7, 2021, just 12 days after receiving Johnson & Johnson/Janssen’s experimental Ad26.COV2.S vaccine for COVID-19. Jessica Berg Wilson, the mother of two young daughters, was vaccinated on Aug. 26 and subsequently developed a blood clotting syndrome, known as “thrombosis with thrombocytopenia syndrome” (TTS), that […]
According to the British Medical Journal (BMJ), more than 30,000 British women experienced changes to their menstrual cycle after getting the COVID-19 vaccine. Reproductive immunologist Victoria Male, PhD wrote an opinion piece for BMJ calling for more research on the subject and stating, “a link is plausible and should be investigated.”1 Reported changes to women’s […]
American pharmaceutical and biotechnology company Moderna, Inc., which partnered with the U.S. National Institutes of Allergy and Infectious Diseases (NIAID) to develop an mRNA COVID-19 vaccine being distributed in the United States under an Emergency Use Authorization (EUA) announced that it is developing a combined single-dose booster vaccine for COVID-19 and seasonal influenza.1 In a […]
Despite not convening the Vaccines and Related Biologic Products Advisory Committee (VRBPAC) last month to vote on effectiveness and safety of the Pfizer-BioNTech COVID-19 vaccine (licensed under the name COMIRNATY), the U.S. Food and Drug Administration (FDA) convened the advisory committee on Friday, Sept. 17, 2021 to vote on booster doses of the vaccine.1 The […]